Literature DB >> 2509778

In vitro generation of dysmorphic erythrocytes.

P Schramek1, A Moritsch, H Haschkowitz, B R Binder, M Maier.   

Abstract

In hematuria, dysmorphic red blood cells found in the urine sediment are known to indicate glomerular origin of bleeding. To better understand the mechanisms which might cause the typical membrane changes in dysmorphic erythrocytes in vivo, we have exposed normal human erythrocytes in vitro to an osmotic and enzymatic environment similar to that of the nephron. In addition, treated or untreated erythrocytes were exposed to a hemolytic environment. The morphology of the cells was evaluated by light and electron microscopy in comparison of that of dysmorphic erythrocytes obtained in vivo. Neither the passage of erythrocytes in sequence through various solutions each simulating the tubule fluid in a different part of the nephron, nor exposure to urinary or renal enzymes or to serum per se causes the typical membrane alterations. Upon exposure of passaged erythrocytes to a hemolytic environment, however, 50 to 90% of the cells become dysmorphic in a time and dose dependent fashion. By light and electron microscopy these dysmorphic erythrocytes obtained in vitro are indistinguishable from those obtained in vivo. In contrast, non-passaged red blood cells are not affected by the same hemolytic environment. We conclude that osmotically challenged erythrocytes exposed to a hemolytic environment develop dysmorphic membrane alterations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509778     DOI: 10.1038/ki.1989.163

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  2 in total

1.  Differentiation of hematuria by quantitative determination of urinary marker proteins.

Authors:  W Hofmann; D Schmidt; W G Guder; H H Edel
Journal:  Klin Wochenschr       Date:  1991-01-22

2.  Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases.

Authors:  Won Seok Yang
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.